Cargando…
Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study
BACKGROUND: A predominant side effect of radiotherapy for head and neck cancer is salivary gland hypofunction and xerostomia leading to debilitating oral disorders and impaired quality of life (QoL). Intraglandular mesenchymal stem cell therapy has shown promising results as a treatment for xerostom...
Autores principales: | Jakobsen, Kathrine Kronberg, Carlander, Amanda-Louise Fenger, Grønhøj, Christian, Todsen, Tobias, Melchiors, Jacob, Paaske, Natasja, Madsen, Anne Kathrine Østergaard, Kastrup, Jens, Ekblond, Annette, Haack-Sørensen, Mandana, Farhadi, Mohammad, Maare, Christian, Friborg, Jeppe, Lynggard, Charlotte Duch, von Buchwald, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474624/ https://www.ncbi.nlm.nih.gov/pubmed/37658468 http://dx.doi.org/10.1186/s13063-023-07594-5 |
Ejemplares similares
-
Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II)
por: Lynggaard, Charlotte Duch, et al.
Publicado: (2022) -
Focal Epithelial Hyperplasia
por: Bendtsen, Simone Kloch, et al.
Publicado: (2021) -
Diagnostic Accuracy of HPV Detection in Patients with Oropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-Analysis
por: Jakobsen, Kathrine Kronberg, et al.
Publicado: (2021) -
First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial
por: Grønhøj, Christian, et al.
Publicado: (2017) -
Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial
por: Lynggaard, Charlotte Duch, et al.
Publicado: (2022)